Launch of an ambitious cross-pharma study by the public-private partnership ‘COVIDRIVE’: a multi-country European study to continuously monitor COVID-19 vaccine effectiveness against severe disease

17/09/2021 - COVIDRIVE, a long-term, multi-country, hospital-based study investigating the [...]

Launch of an ambitious cross-pharma study by the public-private partnership ‘COVIDRIVE’: a multi-country European study to continuously monitor COVID-19 vaccine effectiveness against severe disease2021-09-20T09:35:03+02:00
Go to Top